Study to Evaluate Safety, Pharmacokinetic and Pharmacodynamic Dose Escalation and Expansion Study of PXS-5505 in Patients With Primary, Post-polycythemia Vera or Post-essential Thrombocythemia Myelofibrosis

Clinical trial NCT04676529 · COMPLETED

Trial details

NCT number: NCT04676529
Sponsor: Syntara
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Myelofibrosis Primary Myelofibrosis (PMF)Post- Essential Thrombocythemia Myelofibrosis Post Polycythemia Vera Myelofibrosis

Start date: 2021-02-18
Primary completion: 2025-07-09
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.